Valerio Licursi

1.9k citations
57 papers · 1.2k indexed · h-index 20
Topics
Epigenetics and DNA Methylation (12 papers)MicroRNA in disease regulation (9 papers)RNA modifications and cancer (6 papers)

In The Last Decade

Valerio Licursi

55 papers receiving 1.2k citations

Peers

Valerio Licursi
Comparison fields: 5 of 127
  • Molecular Biology 779
  • Cancer Research 324
  • Oncology 104
  • Plant Science 103
  • Immunology 97
Replace Michael Fähling with:
Michael Fähling Germany
Fumihiko Hakuno Japan
Elitsa Y. Dimova Finland
Yi Jia United States
Indranil Sinha Sweden
Daniel Meley France
Jing Zou China
Dexter T. Duncan United States
Tobias A. Beyer Switzerland
Huimin Zhou China
Valerio Licursi relative to Michael Fähling Germany Michael Fähling's profile →
Citations per field
00.5×1.5×1.9×
Michael Fähling · 1×
Citations per year

Countries citing papers authored by Valerio Licursi

Since Specialization
Citations

This map shows the geographic impact of Valerio Licursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valerio Licursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valerio Licursi more than expected).

Fields of papers citing papers by Valerio Licursi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valerio Licursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valerio Licursi. The network helps show where Valerio Licursi may publish in the future.

Co-authorship network of co-authors of Valerio Licursi

This figure shows the co-authorship network connecting the top 25 collaborators of Valerio Licursi. A scholar is included among the top collaborators of Valerio Licursi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valerio Licursi. Valerio Licursi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 3
3 7
4 4
5 1
6 7
7 2
8 8
9 7
10 26
11 7
12 34
13 15
14 17
15 28
16 23
17 24
18 14
19 35
20 17

About Valerio Licursi

Valerio Licursi is a scholar working on Developmental Neuroscience, Cancer Research and Molecular Biology, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), MicroRNA in disease regulation (9 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (324 citations), Molecular Biology (779 citations) and Biological Psychiatry (17 citations). Valerio Licursi has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Paola Paci, Federica Conte, Giulia Fiscon, Rodolfo Negri, Cecilia Mannironi, Carlo Presutti, Lorenzo Farina, Roberto Amendola, Daniele Bizzarri and Giuseppe Lupo. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026